Compare Datadog Inc (DDOG) vs BIO-TECHNE Corp (TECH) Price & Performance

Datadog (DDOG) trades at $271.34, down 2.48% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while oscillators are neutral. Fundamentally, revenue growth is robust, rising from $1.7B in 2022 to $3.43B in 2025, though net income margins are volatile. Recent earnings beats and accelerating enterprise customer adoption, particularly in AI and cloud observability, support positive sentiment.

The outlook is favorable given analyst consensus and AI-driven demand, but high valuation multiples (P/E 542.68) and negative net cash flow pose risks. Upside potential exists if the company sustains earnings momentum and expands profitability. Key risks include competitive pressures and execution challenges in a high-growth environment.

TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Revenue for 2025 was $1.22B, with a net income margin of 14.97%. Valuation ratios are elevated, with a P/E of 62.46 and P/S of 9.36. A significant development is the shareholder-approved acquisition by Merck KGaA at $73.00 per share, pending completion.

The outlook is heavily influenced by the pending acquisition, offering a near-term price ceiling. Fundamentals show solid profitability but high valuation multiples. Risks include acquisition deal completion uncertainty and integration challenges. Analyst sentiment is mixed with no sell ratings, but the consensus price target of $65.78 suggests limited upside from current levels, making the stock a hold pending acquisition closure.